FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...

The Prefilled Auto Injectors Market is poised for robust expansion driven by escalating incidence of chronic conditions, heightened demand for self-administration therapeutics, and intensifying ...

Ozempic has become so embedded in global culture that “Ozempic face” was shortlisted for a prominent dictionary’s word of the year in 2025. Ozempic isn’t the only drug that mimics the natural GLP-1 ...

Mounjaro significantly reduced hospitalizations in adults with obesity and symptomatic chronic heart failure with preserved ejection fraction.

Six pharmaceutical companies have applied to make a generic version of semaglutide, and competition will continue to heat up ...

An updated edition of the December 16, 2025, article. An aging U.S. population is becoming a first-order driver of consumption reallocation. Going by the data from the United States Census Bureau, by ...

The loveliest skin, health and wellbeing destinations, all in one place ...

A pioneering study marks a major step toward eliminating the need for daily insulin injections for people with diabetes. The ...

The FDA has approved a label update for an inhaled insulin indicated for adults with type 1 or type 2 diabetes, according to ...

Real-world data demonstrate that the MiniMed 780G system effectively controls glucose levels in users who do not administer ...

The US FDA has approved Medtronic’s 780G for use with rapid-acting insulin and with Abbott’s type 2 diabetes-specific sensor.

New Afrezza prescribing information outlines higher starting dose conversions for patients transitioning from mealtime ...